Table 3. The relationship between preoperative histological diagnosis and clinical pathological characteristics of the patients in this group.
| Classification | No. | Purpose of histological diagnosis |
P value | |
|---|---|---|---|---|
| Upfront surgery | Induction therapy | |||
| Tumor size | 7.8±3 | 7.9±2.9 | 0.696 | |
| Masaoka stage | 0.000 | |||
| I | 88 | 81 (42.6%) | 7 (12.1%) | |
| II | 32 | 25 (13.2%) | 7 (12.1%) | |
| III | 93 | 60 (31.6%) | 33 (56.9%) | |
| IV | 35 | 24 (12.6%) | 11 (19.0%) | |
| R resection | 0.025 | |||
| R0 | 178 | 140 (73.7%) | 38 (65.5%) | |
| R1 | 22 | 19 (10%) | 3 (5.2%) | |
| R2 | 48 | 31 (16.3%) | 17 (29.3%) | |
| WHO type | 0.000 | |||
| A + AB | 62 | 59 (33.9%) | 3 (5.4%) | |
| B1 + B2 + B3 | 93 | 70 (40.2%) | 23 (41.1%) | |
| C + NETT | 75 | 45 (25.9%) | 30 (53.6%) | |
WHO, World Health Organization; NETT, neuroendocrine thymic tumour.